Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled study of istradefylline in Parkinson's disease with motor fluctuations
2013-002254-70Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Istradefylline in Parkinson's disease (PD) (3 arms), sponsored by Kyowa Kirin. Primary endpoint: Change from baseline in total hours per day spent in the OFF state. Started Nov 2013; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2013-002254-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002254-70.